OPTUS Pharmaceutical Co., Ltd. (KOSDAQ:131030)
9,390.00
-210.00 (-2.19%)
At close: Apr 28, 2026
48.34% (1Y)
| Market Cap | 165.70B +67.3% |
| Revenue (ttm) | 87.16B +6.4% |
| Net Income | 11.36B +10.2% |
| EPS | 730.00 +8.1% |
| Shares Out | 17.65M |
| PE Ratio | 12.86 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 111,894 |
| Average Volume | 579,884 |
| Open | 9,860.00 |
| Previous Close | 9,600.00 |
| Day's Range | 9,380.00 - 9,860.00 |
| 52-Week Range | 5,950.00 - 20,750.00 |
| Beta | 0.45 |
| RSI | 41.69 |
| Earnings Date | Jan 23, 2026 |